Brugada syndrome is a genetic heart condition that disrupts the electrical signals controlling your heartbeat, potentially triggering dangerous irregular rhythms. It affects roughly 1 to 5 people per 1,000 worldwide, and while many people live without symptoms, it can cause sudden cardiac arrest, sometimes as the very first sign. The condition is a leading cause of sudden cardiac death in otherwise healthy young adults.
How Brugada Syndrome Affects the Heart
Your heart relies on tiny channels in its muscle cells that open and close to let charged particles (ions) flow in and out. This flow of ions creates the electrical impulse that makes the heart contract in a coordinated rhythm. In Brugada syndrome, some of these channels, particularly the ones that control sodium flow, don’t work properly. The result is an electrical imbalance in part of the heart’s right ventricle.
When that imbalance hits a tipping point, the heart can slip into ventricular fibrillation, a chaotic quivering that stops blood from pumping. Without immediate treatment, ventricular fibrillation is fatal within minutes. The risk is highest during rest or sleep, which is why some cardiac events in Brugada syndrome happen at night.
Genetics and Who Gets It
About 30% of confirmed cases trace back to a mutation in a single gene called SCN5A, which provides instructions for building sodium channels. Researchers have identified over 40 other genes linked to the condition, but SCN5A remains the most common and best understood. A person only needs one copy of the faulty gene (inherited from one parent) to have the condition, giving each child of an affected parent a 50% chance of inheriting it.
Brugada syndrome is far more common in Southeast Asia, where the prevalence reaches about 3.7 per 1,000 people. Men are affected roughly six times more often than women in clinical presentation, with prevalence estimates of 0.6 per 1,000 in males compared to 0.1 per 1,000 in females. Testosterone appears to play a role in this disparity, which is why symptoms typically emerge in adulthood rather than childhood. The average age at diagnosis is around 40.
Symptoms to Recognize
Many people with Brugada syndrome have no symptoms at all. Their condition shows up only as an unusual pattern on an electrocardiogram (ECG), sometimes discovered by chance during a routine checkup or a test for something else entirely.
When symptoms do appear, fainting (syncope) is the most common warning sign. Among patients who experience life-threatening arrhythmias, approximately 80% report a prior fainting episode. Other symptoms include palpitations, dizziness, and in rarer cases, gasping or labored breathing during sleep, known as nocturnal agonal respiration. These episodes tend to occur at rest, during sleep, or after a large meal, times when the part of the nervous system that slows the heart is most active.
In the most severe scenario, the first “symptom” is sudden cardiac arrest. This is why identifying the condition before a crisis matters so much, especially when there’s a family history of unexplained sudden death in a young relative.
How It’s Diagnosed
Diagnosis centers on the ECG. Doctors look for a specific pattern called a Type 1 Brugada pattern: a distinctive coved (dome-shaped) elevation of the ST segment in certain chest leads, with a rise of at least 2 mm at a specific point on the tracing, followed by a downsloping segment that dips into an inverted T wave. This pattern must appear in at least two consecutive heartbeats to count.
The tricky part is that this signature pattern can come and go. Someone with Brugada syndrome may have a completely normal ECG on any given day. When the pattern doesn’t show up on its own but suspicion is high, doctors use a provocation test. This involves giving a medication through an IV that temporarily blocks sodium channels, essentially unmasking the hidden electrical abnormality. The test is done under close monitoring in a hospital setting. Ajmaline is the preferred drug for this purpose when available, though flecainide and procainamide are alternatives.
Genetic testing can confirm the diagnosis when a pathogenic variant in SCN5A or another associated gene is found, but a negative genetic test doesn’t rule the condition out. Since only about 30% of cases involve SCN5A, many patients have a clinical diagnosis without a confirmed genetic cause.
Triggers That Increase Risk
Fever is one of the most important and avoidable triggers. Elevated body temperature can worsen the dysfunction of already impaired sodium channels, potentially provoking a dangerous rhythm. People with Brugada syndrome are advised to treat fevers promptly and aggressively with fever-reducing medication.
A long list of medications can also unmask or worsen the condition. The major categories include:
- Certain antidepressants, particularly older tricyclic types
- Some antiarrhythmic drugs, ironically the very medications used to treat other heart rhythm problems
- Certain anesthetics, which is why it’s critical to inform surgical teams about the diagnosis
- Cocaine and excessive alcohol, both of which can provoke arrhythmias
- Some psychiatric medications, including lithium and certain antipsychotics
An international database (brugadadrugs.org) maintains a current list of drugs to avoid. Carrying this information and sharing it with every new healthcare provider is a practical step that can prevent accidental exposure to a dangerous trigger.
Treatment and Long-Term Management
There is no cure for Brugada syndrome, so treatment focuses on preventing sudden cardiac death. For people who have survived a cardiac arrest or who have documented dangerous arrhythmias, an implantable cardioverter-defibrillator (ICD) is the primary treatment. This small device, placed under the skin near the collarbone, continuously monitors heart rhythm and delivers an electric shock to restore a normal beat if it detects a life-threatening arrhythmia.
For people diagnosed through an ECG finding but who have never had symptoms, the decision about an ICD is more nuanced. Doctors weigh the individual’s risk profile, including whether the dangerous pattern appears spontaneously or only with provocation, family history of sudden death, and results of specialized electrophysiology testing. Living with an ICD means periodic device checks, eventual battery replacements every several years, and some lifestyle adjustments, but the device can be lifesaving.
A newer option for selected patients is catheter ablation, a procedure that targets and destroys the small area of abnormal heart tissue responsible for generating the faulty electrical signals. Early results are promising, with some patients showing normalization of their ECG pattern after the procedure, though long-term data is still accumulating.
For everyone with Brugada syndrome, regardless of whether they receive a device, the daily management strategy is straightforward: avoid known drug triggers, treat fevers early, limit heavy alcohol use, and ensure that family members are screened. Because the condition is inherited, first-degree relatives (parents, siblings, children) should be evaluated with an ECG and potentially genetic testing.